Clinical characterization of familial hypercholesterolemia due to an amish founder mutation in Apolipoprotein B

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1471-2261

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Clinical characterization of familial hypercholesterolemia due to an amish founder mutation in Apolipoprotein B ; volume:22 ; number:1 ; day:17 ; month:3 ; year:2022 ; pages:1-10 ; date:12.2022
BMC cardiovascular disorders ; 22, Heft 1 (17.3.2022), 1-10, 12.2022

Creator: Williams, Katie B.
Horst, Michael
Young, Millie
Pascua, Christine
Puffenberger, Erik G.
Brigatti, Karlla W.
Gonzaga-Jauregui, Claudia
Shuldiner, Alan R.
Gidding, Samuel
Strauss, Kevin A.
Chowdhury, Devyani

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12872-022-02539-3

URN: urn:nbn:de:101:1-2022060919540559133213

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:24 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Williams, Katie B.
Horst, Michael
Young, Millie
Pascua, Christine
Puffenberger, Erik G.
Brigatti, Karlla W.
Gonzaga-Jauregui, Claudia
Shuldiner, Alan R.
Gidding, Samuel
Strauss, Kevin A.
Chowdhury, Devyani
SpringerLink (Online service)

Other Objects (12)

Familial Hypercholesterolemia: new therapeutic approaches

Sex Differences in Familial Hypercholesterolemia

Familial hypercholesterolemia mutations in Petrozavodsk: no similarity to St. Petersburg mutation spectrum

Familial Hypercholesterolemia: Present and Future Management

The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia

A genome sequencing array for time and cost-effective familial hypercholesterolemia mutation analysis

Current causes of death in familial hypercholesterolemia

Familial hypercholesterolemia in very young myocardial infarction

Deploying Clinical Decision Support for Familial Hypercholesterolemia

An update on lipid apheresis for familial hypercholesterolemia

MicroRNAs: New Therapeutic Targets for Familial Hypercholesterolemia?

Hypercholesterolemia and apolipoprotein B expression: Regulation by selenium status

Familial Hypercholesterolemia: new therapeutic approaches

Sex Differences in Familial Hypercholesterolemia

Familial hypercholesterolemia mutations in Petrozavodsk: no similarity to St. Petersburg mutation spectrum

Familial Hypercholesterolemia: Present and Future Management

The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia

A genome sequencing array for time and cost-effective familial hypercholesterolemia mutation analysis

Current causes of death in familial hypercholesterolemia

Familial hypercholesterolemia in very young myocardial infarction

Deploying Clinical Decision Support for Familial Hypercholesterolemia

An update on lipid apheresis for familial hypercholesterolemia

MicroRNAs: New Therapeutic Targets for Familial Hypercholesterolemia?

Hypercholesterolemia and apolipoprotein B expression: Regulation by selenium status

Familial Hypercholesterolemia: new therapeutic approaches

Sex Differences in Familial Hypercholesterolemia

Familial hypercholesterolemia mutations in Petrozavodsk: no similarity to St. Petersburg mutation spectrum

Familial Hypercholesterolemia: Present and Future Management

The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia

A genome sequencing array for time and cost-effective familial hypercholesterolemia mutation analysis

Current causes of death in familial hypercholesterolemia

Familial hypercholesterolemia in very young myocardial infarction

Deploying Clinical Decision Support for Familial Hypercholesterolemia

An update on lipid apheresis for familial hypercholesterolemia

MicroRNAs: New Therapeutic Targets for Familial Hypercholesterolemia?

Hypercholesterolemia and apolipoprotein B expression: Regulation by selenium status

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Clinical characterization of familial hypercholesterolemia due to an amish founder mutation in Apolipoprotein B

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Familial Hypercholesterolemia: new therapeutic approaches

Sex Differences in Familial Hypercholesterolemia

Familial hypercholesterolemia mutations in Petrozavodsk: no similarity to St. Petersburg mutation spectrum

Familial Hypercholesterolemia: Present and Future Management

The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia

A genome sequencing array for time and cost-effective familial hypercholesterolemia mutation analysis

Current causes of death in familial hypercholesterolemia

Familial hypercholesterolemia in very young myocardial infarction

Deploying Clinical Decision Support for Familial Hypercholesterolemia

An update on lipid apheresis for familial hypercholesterolemia

MicroRNAs: New Therapeutic Targets for Familial Hypercholesterolemia?

Hypercholesterolemia and apolipoprotein B expression: Regulation by selenium status

Familial Hypercholesterolemia: new therapeutic approaches

Sex Differences in Familial Hypercholesterolemia

Familial hypercholesterolemia mutations in Petrozavodsk: no similarity to St. Petersburg mutation spectrum

Familial Hypercholesterolemia: Present and Future Management

The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia

A genome sequencing array for time and cost-effective familial hypercholesterolemia mutation analysis

Current causes of death in familial hypercholesterolemia

Familial hypercholesterolemia in very young myocardial infarction

Deploying Clinical Decision Support for Familial Hypercholesterolemia

An update on lipid apheresis for familial hypercholesterolemia

MicroRNAs: New Therapeutic Targets for Familial Hypercholesterolemia?

Hypercholesterolemia and apolipoprotein B expression: Regulation by selenium status

Familial Hypercholesterolemia: new therapeutic approaches

Sex Differences in Familial Hypercholesterolemia

Familial hypercholesterolemia mutations in Petrozavodsk: no similarity to St. Petersburg mutation spectrum

Familial Hypercholesterolemia: Present and Future Management

The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia

A genome sequencing array for time and cost-effective familial hypercholesterolemia mutation analysis

Current causes of death in familial hypercholesterolemia

Familial hypercholesterolemia in very young myocardial infarction

Deploying Clinical Decision Support for Familial Hypercholesterolemia

An update on lipid apheresis for familial hypercholesterolemia

MicroRNAs: New Therapeutic Targets for Familial Hypercholesterolemia?

Hypercholesterolemia and apolipoprotein B expression: Regulation by selenium status

Related objects

Reset password